PetMed Express (PETS) Projected to Announce Quarterly Earnings on Tuesday

PetMed Express (NASDAQ:PETS) will likely be announcing its Q2 2027 resultson Tuesday, October 13th. Analysts expect PetMed Express to announce earnings of ($0.11) per share and revenue of $62.00 million for the quarter. Individuals can check the company’s upcoming Q2 2027 earnings summary page for the latest details on the call scheduled for Monday, November 2, 2026 at 4:00 PM ET.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.40). The company had revenue of $41.02 million during the quarter, compared to analysts’ expectations of $71.00 million. PetMed Express had a negative return on equity of 91.69% and a negative net margin of 17.34%. On average, analysts expect PetMed Express to post ($0.50) EPS for the current fiscal year and ($0.35) EPS for the next fiscal year.

PetMed Express Stock Performance

PETS opened at $1.28 on Monday. The firm has a market cap of $27.86 million, a P/E ratio of -0.93 and a beta of 0.83. The firm has a 50-day moving average of $1.70 and a 200 day moving average of $1.95. PetMed Express has a fifty-two week low of $1.26 and a fifty-two week high of $4.10.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on PETS shares. Zacks Research cut shares of PetMed Express from a “hold” rating to a “strong sell” rating in a research note on Friday, September 25th. Morgan Stanley decreased their price target on shares of PetMed Express from $2.15 to $1.40 and set an “underweight” rating for the company in a research note on Friday, September 25th. Wall Street Zen lowered shares of PetMed Express from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Finally, Weiss Ratings cut shares of PetMed Express from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, September 29th. Three research analysts have rated the stock with a Sell rating. According to data from MarketBeat.com, PetMed Express currently has an average rating of “Strong Sell” and a consensus price target of $1.40.

PetMed Express Company Profile

PetMed Express, Inc is an online pet pharmacy and specialty retailer that markets pet medications, food, and healthcare products directly to consumers. The company operates under the 1-800-PetMeds brand and focuses primarily on products for dogs and cats.

Its product offerings include prescription and nonprescription medications, flea and tick treatments, heartworm preventives, supplements, and other veterinary health products. PetMed Express also sells pet food, treats, supplies, and select general wellness products through its digital platforms and customer service channels.

Founded in 1996, the company serves pet owners throughout the United States.